The generic and biosimilar industry is an American success, bringing prices down and making people healthier. The Association for Accessible Medicines and its members devise patient-centered solutions in a market-driven environment. Generic medicines comprise nearly 90% of all prescriptions filled in the United States every year yet represent only 27% of total drug costs. Over the next ten years, biosimilars are projected to save our health care system $250 billion. Share this video to show your support of the #medswithinreach campaign.
